Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04565509 · ClinicalTrials.gov registry record · NA
Supporting the Health and Well-being of Children With Intellectual and Developmental Disability During COVID-19 Pandemic
A NA study of Covid19 and Intellectual Disability, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 1,143
- Enrollment target
- 3
- Study locations
NCT04565509 is a NA study of Covid19 and Intellectual Disability that has completed, run by Washington University School of Medicine. The registered enrollment target is 1,143 participants, below the 2,690-participant average among 94 other Covid19 trials with a reported enrollment target (58% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT04565509, a NA study of Covid19 and Intellectual Disability, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,143 participants
- Enrollment target
- 3
- Study locations
Study Summary
The primary goal of this project is to identify the best messaging and implementation strategies to maximize SARS-CoV-2 testing for children with intellectual and developmental disabilities (IDD) and their teachers to help ensure a safe school environment. Additionally, we will understand nationally the perceptions of COVID-19 and identify facilitators and barriers to help with the adoption of testing in other parts of the US and the necessary strategies to address other mitigation strategies including vaccination.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST COVID-19 Testing
- BEHAVIORAL Focus Groups
- BEHAVIORAL Standard Messaging
- BEHAVIORAL Enhanced Messaging
- BEHAVIORAL Fuzzy Cognitive Mapping
Study Locations (3)
Missouri
- University of Missouri - Kansas City
- Special School District - St Louis
Maryland
- Hugo W. Moser Research Institute at Kennedy Krieger, Inc. - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,143 participants |
| Start Date | 2020-11-20 |
| Est. Completion | 2024-03-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04565509
The ClinicalTrials.gov registry entry for NCT04565509 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,143 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,690-participant average among 94 other Covid19 trials with a reported enrollment target (58% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Covid19 appearing as the primary indexed condition, and to 5 interventions - of which COVID-19 Testing is the first listed.
NCT04565509 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Missouri, Maryland.
Frequently Asked Questions
What is clinical trial NCT04565509 about?
NCT04565509 is a clinical study titled "Supporting the Health and Well-being of Children With Intellectual and Developmental Disability During COVID-19 Pandemic". The primary goal of this project is to identify the best messaging and implementation strategies to maximize SARS-CoV-2 testing for children with intellectual and developmental disabilities (IDD) and their teachers to help ensure a safe school environment. Additionally, we will understand nationally...
What is the current status of trial NCT04565509?
This trial is currently completed. It is a NA study. The enrollment target is 1,143 participants. The study started on 2020-11-20. Estimated completion is 2024-03-29.
What conditions does trial NCT04565509 study?
This clinical trial studies the following conditions: Covid19, Intellectual Disability, Developmental Disability, Child Development Disorder.
What interventions are being tested in trial NCT04565509?
The interventions under investigation include: COVID-19 Testing (DIAGNOSTIC_TEST), Focus Groups (BEHAVIORAL), Standard Messaging (BEHAVIORAL), Enhanced Messaging (BEHAVIORAL), Fuzzy Cognitive Mapping (BEHAVIORAL).
Who is sponsoring clinical trial NCT04565509?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04565509 being conducted?
This trial has 3 study locations across Maryland, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Covid19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Multimodal Parent-focused Intervention for Vulnerable Populations in the Bronx
RECRUITING · NA
-
Improving Health Equity for COVID-19 Vaccination for At-risk Populations Using Online Social Networks
ACTIVE NOT RECRUITING · NA
-
Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs
ACTIVE NOT RECRUITING · NA
-
A Study To Evaluate The Performance of the Lucira Health All-In-One COVID-19 Test Kit vs Hologic Panther Fusion
COMPLETED · NA
-
Implementation of COVID-19 Testing Strategies in Community Health Centers
COMPLETED · NA
-
Minnesota COVID-19 Testing Project
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.